Patents by Inventor Veronika Rayzman

Veronika Rayzman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD131 binding proteins and uses thereof
    Patent number: 11840573
    Abstract: The present disclosure provides a CD131-binding protein comprising an antigen binding domain of an antibody, wherein the antigen binding domain binds to or specifically binds to CD131 and neutralizes signaling by interleukin (IL) 3, IL-5 and granulocyte-macrophage colony stimulating factor (GM-CSF), and uses thereof.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: December 12, 2023
    Assignee: CSL LIMITED
    Inventors: Catherine Owczarek, Con Panousis, Nicholas Wilson, Matthew Hardy, Kirsten Edwards, Veronika Rayzman
  • Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies
    Patent number: 11345759
    Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.
    Type: Grant
    Filed: November 5, 2019
    Date of Patent: May 31, 2022
    Assignees: CSL Behring GmbH, CSL Ltd
    Inventors: Con Panousis, Veronika Rayzman, Andrew Nash, Michael Wilson, Stefan Schmidbauer, Marc Nolte
  • CD131 BINDING PROTEINS AND USES THEREOF
    Publication number: 20210324091
    Abstract: The present disclosure provides a CD131-binding protein comprising an antigen binding domain of an antibody, wherein the antigen binding domain binds to or specifically binds to CD131 and neutralizes signaling by interleukin (IL) 3, IL-5 and granulocyte-macrophage colony stimulating factor (GM-CSF), and uses thereof.
    Type: Application
    Filed: November 20, 2020
    Publication date: October 21, 2021
    Inventors: Catherine OWCZAREK, Kosta PANOUSIS, Nicholas WILSON, Matthew HARDY, Kirsten EDWARDS, Veronika RAYZMAN
  • CD131 binding proteins
    Patent number: 10894834
    Abstract: The present disclosure provides a CD131-binding protein comprising an antigen binding domain of an antibody, wherein the antigen binding domain binds to or specifically binds to CD131 and neutralizes signaling by interleukin (IL) 3, IL-5 and granulocyte-macrophage colony stimulating factor (GM-CSF), and uses thereof.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: January 19, 2021
    Assignee: CSL LIMITED
    Inventors: Catherine Owczarek, Kosta Panousis, Nicholas Wilson, Matthew Hardy, Kirsten Edwards, Veronika Rayzman
  • METHODS OF ADMINISTERING INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES
    Publication number: 20200062863
    Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.
    Type: Application
    Filed: November 5, 2019
    Publication date: February 27, 2020
    Inventors: Con Panousis, Veronika Rayzman, Andrew Nash, Michael Wilson, Stefan Schmidbauer, Marc Nolte
  • Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies
    Patent number: 10513560
    Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.
    Type: Grant
    Filed: November 27, 2017
    Date of Patent: December 24, 2019
    Assignees: CSL Behring GmbH, CSL Ltd.
    Inventors: Con Panousis, Veronika Rayzman, Andrew Nash, Michael Wilson, Stefan Schmidbauer, Marc Nolte
  • CD131 BINDING PROTEINS AND USES THEREOF
    Publication number: 20190062438
    Abstract: The present disclosure provides a CD131-binding protein comprising an antigen binding domain of an antibody, wherein the antigen binding domain binds to or specifically binds to CD131 and neutralizes signaling by interleukin (IL) 3, IL-5 and granulocyte-macrophage colony stimulating factor (GM-CSF), and uses thereof.
    Type: Application
    Filed: November 25, 2016
    Publication date: February 28, 2019
    Inventors: Catherine OWCZAREK, Kosta PANOUSIS, Nicholas WILSON, Matthew HARDY, Kirsten EDWARDS, Veronika RAYZMAN
  • METHODS OF ADMINISTERING INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES
    Publication number: 20180134806
    Abstract: The invention relates to inhibitory anti-factor XII/FXIla antibodies and methods of their use.
    Type: Application
    Filed: November 27, 2017
    Publication date: May 17, 2018
    Inventors: Con Panousis, Veronika Rayzman, Andrew Nash, Michael Wilson, Stefan Schmidbauer, Marc Nolte
  • Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies
    Patent number: 9856326
    Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: January 2, 2018
    Assignees: CSL Behring GmbH, CSL Ltd.
    Inventors: Con Panousis, Veronika Rayzman, Andrew Nash, Michael Wilson, Stefan Schmidbauer, Marc Nolte
  • Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodies
    Patent number: 9856325
    Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: January 2, 2018
    Assignees: CSL Behring GmbH, CSL Ltd.
    Inventors: Con Panousis, Veronika Rayzman, Andrew Nash, Michael Wilson, Stefan Schmidbauer, Marc Nolte
  • Fibronectin III domain of IL-11R?
    Patent number: 9796782
    Abstract: The present disclosure provides proteins comprising antigen binding sites of antibodies that bind to interleukin-11 (IL-11) receptor alpha (IL-11R?) and uses thereof, e.g., in therapy.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: October 24, 2017
    Assignee: CSL LIMITED
    Inventors: Kirsten Edwards, Matthew Hardy, Veronika Rayzman, Michael Wilson
  • INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES
    Publication number: 20170137536
    Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.
    Type: Application
    Filed: November 4, 2016
    Publication date: May 18, 2017
    Applicants: CSL Behring GmbH, CSL Ltd.
    Inventors: Con Panousis, Veronika Rayzman, Andrew Nash, Michael Wilson, Stefan Schmidbauer, Marc Nolte
  • INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES
    Publication number: 20170121423
    Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.
    Type: Application
    Filed: November 4, 2016
    Publication date: May 4, 2017
    Applicants: CSL Behring GmbH, CSL Ltd.
    Inventors: Con Panousis, Veronika Rayzman, Andrew Nash, Michael Wilson, Stefan Schmidbauer, Marc Nolte
  • Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses
    Patent number: 9518127
    Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: December 13, 2016
    Assignees: CSL Behring GmbH, CSL Ltd.
    Inventors: Con Panousis, Veronika Rayzman, Andrew Nash, Michael Wilson, Stefan Schmidbauer, Marc Nolte
  • IL-11R binding proteins
    Patent number: 9340618
    Abstract: The present disclosure provides proteins comprising antigen binding sites of antibodies that bind to interleukin-11 (IL-11) receptor alpha (IL-11R?) and uses thereof, e.g., in therapy.
    Type: Grant
    Filed: February 6, 2014
    Date of Patent: May 17, 2016
    Assignee: CSL LIMITED
    Inventors: Kirsten Edwards, Matthew Hardy, Veronika Rayzman, Michael Wilson
  • IL-11R BINDING PROTEINS
    Publication number: 20160031999
    Abstract: The present disclosure provides proteins comprising antigen binding sites of antibodies that bind to interleukin-11 (IL-11) receptor alpha (IL-11R?) and uses thereof, e.g., in therapy.
    Type: Application
    Filed: October 19, 2015
    Publication date: February 4, 2016
    Applicant: 45 Poplar Road
    Inventors: Kirsten EDWARDS, Matthew HARDY, Veronika RAYZMAN, Michael WILSON
  • IL-11R BINDING PROTEINS AND USES THEREOF
    Publication number: 20140219919
    Abstract: The present disclosure provides proteins comprising antigen binding sites of antibodies that bind to interleukin-11 (IL-11) receptor alpha (IL-11R?) and uses thereof, e.g., in therapy.
    Type: Application
    Filed: February 6, 2014
    Publication date: August 7, 2014
    Applicant: CSL Limited
    Inventors: Kirsten EDWARDS, Matthew HARDY, Veronika RAYZMAN, Michael WILSON
  • INHIBITORY ANTI-FACTOR XII/XIIA MONOCLONAL ANTIBODIES AND THEIR USES
    Publication number: 20140199361
    Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.
    Type: Application
    Filed: July 20, 2012
    Publication date: July 17, 2014
    Inventors: Con Panousis, Veronika Rayzman, Andrew Nash, Michael Wilson, Stefan Schmidbauer, Marc Nolte